Canadians secretly love Mark "Mean" Carney BECAUSE he yells

In the latest episode of The Line Podcast, recorded on June 5th, 2026, Matt Gurney and Jen Gerson begin with reports that Prime Minister Mark Carney has a tendency to raise his voice behind closed doors when dealing with his Liberal caucus. According to reporting in the Toronto Star, the PM may not always be the calm technocrat he appears to be in public. Your hosts cannot endorse a toxic workplace, of course, but they also suspect many Canadians won’t be especially upset by the news. After all, they argue, a lot of voters chose the Liberals out of necessity rather than affection, and more than a few people might conclude that after a decade of terrible Liberal management, the former PM's leftovers deserve a real chewing out.This episode is brought to you by the Forest Products Association of Canada. Canada’s forest industry is a national economic anchor rooted in hundreds of communities across the country. The Canadian Forest Sector Transformation Task Force was created to chart a path toward a stronger, more competitive, and more resilient sector. That means practical federal action on long-standing priorities: stronger supply chains, better productivity, more homes, and regional resilience. Learn more at FPAC.ca.After that, they discuss Carney’s recent efforts to reassure Canada’s Jewish community. Both hosts agree the attempt fell short. Matt argues that putting Marc Miller in charge of a new advisory panel feels like a very Trudeau-era response to a serious problem — process instead of action. Jen then raises reports that the Trump administration may consider offering asylum to Canadian Jews. She also notes, to Matt's horror, that he warned months ago that such a possibility could eventually arise. Perhaps, they joke, he manifested it.This episode is also brought to you by BioCanRx. Nearly half of all Canadians will face a cancer diagnosis in their lives, and Canadian scientists are racing to build better treatments. But it's not just the science — it's the logistics of actually getting it to patients.BioCanRx is a federally funded, not-for-profit research network that specializes in moving Canadian cancer immunotherapy from the lab to clinical trials here at home. Since 2015, they've funded sixteen trials and treated more than four hundred patients — all with made-in-Canada technology.So what is immunotherapy? Your immune system eliminates threats every day, including your own cells when they mutate. But sometimes mutating cells are able to evade the immune system — and that's usually when we call them cancer. Immunotherapy supports or modifies your immune system so cancer can't slip past it.Stay tuned this summer, and visit BioCanRx.com to learn more.Finally, the hosts check back in on Alberta after what was, by recent standards, a surprisingly quiet week. Probably won't stay that way for long, though. It never does.Also: Ricky Martin reference!All that and more in the latest episode of The Line Podcast.#TheLinePodcast#MarkCarney#CanadianPolitics#CanadaPolitics#AlbertaPolitics#MarcMiller#CanadianJews#MediaAnalysis#FederalPolitics#CurrentAffairs